Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIV and TIV Influenza Vaccines in Children
NCT01246999Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Oct 2010
- Primary completion
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) and trivalent influenza vaccine in influenza, sponsored by University of Rochester. Started Oct 2010; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01246999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246999.